3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoic acid;methyl 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoate
C37H36N10O4S2 — CID 158308821
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoic acid;methyl 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoate
3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoic acid;methyl 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoate (PubChem CID 158308821) has the molecular formula C37H36N10O4S2 and a molecular weight of 748.89 g/mol. Its IUPAC name is 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoic acid;methyl 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoate.
Molecular Properties
| Compound Name | 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoic acid;methyl 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoate |
|---|---|
| PubChem CID | 158308821 |
| Molecular Formula | C37H36N10O4S2 |
| Molecular Weight | 748.89 g/mol |
| Exact Mass | 748.24 |
| IUPAC Name | 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoic acid;methyl 3-[8-(2-aminoethylamino)-12-methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,7,9,11-pentaen-4-yl]benzoate |
| SMILES | COC(=O)c1cccc(-c2cc3nc(NCCN)c4ncc(C)n4c3s2)c1.Cc1cnc2c(NCCN)nc3cc(-c4cccc(C(=O)O)c4)sc3n12 |
| InChI | InChI=1S/C19H19N5O2S.C18H17N5O2S/c1-11-10-22-17-16(21-7-6-20)23-14-9-15(27-18(14)24(11)17)12-4-3-5-13(8-12)19(25)26-2;1-10-9-21-16-15(20-6-5-19)22-13-8-14(26-17(13)23(10)16)11-3-2-4-12(7-11)18(24)25/h3-5,8-10H,6-7,20H2,1-2H3,(H,21,23);2-4,7-9H,5-6,19H2,1H3,(H,20,22)(H,24,25) |
| InChIKey | GNKSPLFTSUJYOU-UHFFFAOYSA-N |
| XLogP | 6.06 |
| TPSA | 200.08 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 748.89 |
| LogP ≤ 5 | 6.06 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158308821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.